In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Warner Chilcott completes $1bn IPO

Executive Summary

Warner Chilcott (hormone therapeutics for women's health and dermatology conditions) has completed its IPO, netting just over $1bn with the sale of 70.6mm common shares at $15 each. The offering price was slightly under the asking price of between $17-19. The company will trade on Nasdaq again, just under two years after being bought out by Bain Capital, DLJ Merchant Banking, JP Morgan, and Thomas H. Lee Partners for $2.9bn.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies